Biomarin Pharmaceutical Inc. (BMRN): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Biomarin Pharmaceutical ( BMRN) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.9%. By the end of trading, Biomarin Pharmaceutical rose $0.72 (1.1%) to $63.34 on light volume. Throughout the day, 878,556 shares of Biomarin Pharmaceutical exchanged hands as compared to its average daily volume of 1,458,200 shares. The stock ranged in a price between $62.27-$64.01 after having opened the day at $62.33 as compared to the previous trading day's close of $62.62. Other companies within the Health Care sector that increased today were: Opexa Therapeutics ( OPXA), up 131.8%, iBio ( IBIO), up 24.9%, Tornier N.V ( TRNX), up 22.5% and Oxygen Biotherapeutics ( OXBT), up 17.9%.

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Biomarin Pharmaceutical has a market cap of $9.0 billion and is part of the drugs industry. Shares are up 27.3% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Biomarin Pharmaceutical a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Biomarin Pharmaceutical as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good.

On the negative front, Pingtan Marine Enterprise ( PME), down 85.0%, Mast Therapeutics ( MSTX), down 40.6%, Nanosphere ( NSPH), down 29.1% and Inovio Pharmaceuticals ( INO), down 26.1% , were all laggards within the health care sector with Tenet Healthcare ( THC) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.